Home › Funds › Bronte Capital Management Pty Ltd. › NKTR

Bronte Capital Management Pty Ltd. position in NKTR

NEKTAR THERAPEUTICS · Health Care

Bronte Capital Management Pty Ltd. reported holding 202,057 shares of NKTR (NEKTAR THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 1.58% of its reported portfolio and ranking #17 among its reported holdings. Bronte Capital Management Pty Ltd. has disclosed NKTR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)202.06K sh
Reported value held$12.23M
Portfolio Weight1.58%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Bronte Capital Management Pty Ltd.'s NKTR position evolved

Bronte Capital Management Pty Ltd. first disclosed a stake in NKTR in Q1 2026 at 198,256 shares (US$14.3M). Across 3 filings, Bronte Capital Management Pty Ltd. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 202,057 shares valued at US$12.2M — an increase of 3,623 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 198.26K $14.26M New
Q2 2026 198.43K $13.85M Hold
Q3 2026 202.06K $12.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS) is a Health Care company. 57 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$166.9M), Vestal Point Capital, LP (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has Bronte Capital Management Pty Ltd. held NKTR?

Bronte Capital Management Pty Ltd. has disclosed NKTR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Bronte Capital Management Pty Ltd.'s current position in NKTR?

As of Q3 2026, Bronte Capital Management Pty Ltd. holds 202.06K shares of NKTR (NEKTAR THERAPEUTICS), valued at $12.23M, representing 1.58% of its reported portfolio and ranking #17.

Has Bronte Capital Management Pty Ltd. been buying or selling NKTR?

In the latest 13F filing (Q3 2026), Bronte Capital Management Pty Ltd. increased its position in NKTR.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Vestal Point Capital, LP, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.